Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial.

Hecht M, Eckstein M, Kallies A, Klautke G, Illmer T, von der Grün J, Laban S, Hautmann M, Tamaskovics B, Hinke A, Brunner T, Frey B, Semrau S, Hartmann A, Balermpas P, Budach W, Gaipl U, Iro H, Gostian AO, Fietkau R (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Journal of Clinical Oncology American Society of Clinical Oncology

Publisher: LIPPINCOTT WILLIAMS & WILKINS

City/Town: PHILADELPHIA

Conference Proceedings Title: JOURNAL OF CLINICAL ONCOLOGY

DOI: 10.1200/jco.2022.40.16_suppl.6064

Authors with CRIS profile

Markus Hecht Department of Radiation Oncology Markus Eckstein Institute of Pathology Annett Kallies Department of Radiation Oncology Gunther Klautke Medizinische Fakultät Benjamin Frey Department of Radiation Oncology Sabine Semrau Medizinische Fakultät Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Udo Gaipl Department of Radiation Oncology Heinrich Iro Lehrstuhl für Hals-, Nasen- und Ohrenheilkunde Antoniu-Oreste Gostian Department of Otorhinolaryngology – Head and Neck Surgery Rainer Fietkau Lehrstuhl für Strahlentherapie

Involved external institutions

Universitätsklinikum Magdeburg A.ö.R. DE Germany (DE) Universitätsspital Zürich (USZ) CH Switzerland (CH) Heinrich-Heine-Universität Düsseldorf DE Germany (DE) Goethe-Universität Frankfurt am Main DE Germany (DE) Onkozentrum Dresden/Freiberg DE Germany (DE) Universität Ulm DE Germany (DE) Universitätsklinikum Düsseldorf DE Germany (DE) Universitätsklinikum Regensburg DE Germany (DE)

How to cite

APA:

Hecht, M., Eckstein, M., Kallies, A., Klautke, G., Illmer, T., von der Grün, J.,... Fietkau, R. (2022). Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. In JOURNAL OF CLINICAL ONCOLOGY. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

MLA:

Hecht, Markus, et al. "Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial." Proceedings of the JOURNAL OF CLINICAL ONCOLOGY PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2022.

BibTeX: Download